Direktorat Registrasi ObatValid

FUROSEMIDE

BPOM Number: GKL8920904910A1
Approved: 22 August 2025
Expiry: 22 August 2030
Form: Tablet

About This Registration

FUROSEMIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL8920904910A1. Its current registration status is Valid, with the licence valid until 22 August 2030. The product is registered to INDOFARMA - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INDOFARMA - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

INDOFARMA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

FUROSEMIDE

Market Intelligence

Owner Portfolio: INDOFARMA - INDONESIA holds 195 BPOM registrations
Manufacturer Scale: INDOFARMA - INDONESIA produces 195 registered products
Registration Age: Registered for 1 year

FDA Cross-Reference

via openFDA

Generic Name: FUROSEMIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?